Global Diabetes Drugs Market Growth 2020-2025

Publisher Name :
Date: 15-Sep-2020
No. of pages: 163

According to this study, over the next five years the Diabetes Drugs market will register a 5.6%% CAGR in terms of revenue, the global market size will reach $ 77400 million by 2025, from $ 62240 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diabetes Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Diabetes Drugs, covering the supply chain analysis, impact assessment to the Diabetes Drugs market size growth rate in several scenarios, and the measures to be undertaken by Diabetes Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Sulphonylureas

- Biguanides

- Meglitinides

- Thiazolidinediones

- Alpha-glucosidase Inhibitors

- DPP-4 Inhibitors

- SGLT-2 Inhibitors

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Diagnostic/Clinics

- ICUs

- Home Healthcare

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Sanofi

- Hisun Pharmacy

- Novo Nordisk

- Astrazeneca

- Takeda

- MSD

- Huadong Medicine

- Novartis

- Dongbao Pharmaceutical

- North China Pharmaceutical Group Corporation

- SHIJIAZHUANG YILING PHARMACEUTICAL

- Gan & Lee

- Wanbang Biopharmaceuticals

- KELUN

- Jumpcan Pharmacy

- Tianan Pharmaceutical

- Guangzhou Baiyun Mountain

- Ginwa

- Taloph

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Diabetes Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Diabetes Drugs market by identifying its various subsegments.

- Focuses on the key global Diabetes Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Diabetes Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Diabetes Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Diabetes Drugs Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetes Drugs Consumption 2015-2025
2.1.2 Diabetes Drugs Consumption CAGR by Region
2.2 Diabetes Drugs Segment by Type
2.2.1 Sulphonylureas
2.2.2 Biguanides
2.2.3 Meglitinides
2.2.4 Thiazolidinediones
2.2.5 Alpha-glucosidase Inhibitors
2.2.6 DPP-4 Inhibitors
2.2.7 SGLT-2 Inhibitors
2.3 Diabetes Drugs Consumption by Type
2.3.1 Global Diabetes Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Diabetes Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Diabetes Drugs Sale Price by Type (2015-2020)
2.4 Diabetes Drugs Segment by Application
2.4.1 Diagnostic/Clinics
2.4.2 ICUs
2.4.3 Home Healthcare
2.5 Diabetes Drugs Consumption by Application
2.5.1 Global Diabetes Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Diabetes Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Diabetes Drugs Sale Price by Type (2015-2020)

3 Global Diabetes Drugs by Company
3.1 Global Diabetes Drugs Sales Market Share by Company
3.1.1 Global Diabetes Drugs Sales by Company (2018-2020)
3.1.2 Global Diabetes Drugs Sales Market Share by Company (2018-2020)
3.2 Global Diabetes Drugs Revenue Market Share by Company
3.2.1 Global Diabetes Drugs Revenue by Company (2018-2020)
3.2.2 Global Diabetes Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Diabetes Drugs Sale Price by Company
3.4 Global Diabetes Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Diabetes Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Diabetes Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Diabetes Drugs by Regions
4.1 Diabetes Drugs by Regions
4.2 Americas Diabetes Drugs Consumption Growth
4.3 APAC Diabetes Drugs Consumption Growth
4.4 Europe Diabetes Drugs Consumption Growth
4.5 Middle East & Africa Diabetes Drugs Consumption Growth

5 Americas
5.1 Americas Diabetes Drugs Consumption by Countries
5.1.1 Americas Diabetes Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Diabetes Drugs Value by Countries (2015-2020)
5.2 Americas Diabetes Drugs Consumption by Type
5.3 Americas Diabetes Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Diabetes Drugs Consumption by Regions
6.1.1 APAC Diabetes Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Diabetes Drugs Value by Regions (2015-2020)
6.2 APAC Diabetes Drugs Consumption by Type
6.3 APAC Diabetes Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Diabetes Drugs by Countries
7.1.1 Europe Diabetes Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Diabetes Drugs Value by Countries (2015-2020)
7.2 Europe Diabetes Drugs Consumption by Type
7.3 Europe Diabetes Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Diabetes Drugs by Countries
8.1.1 Middle East & Africa Diabetes Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Diabetes Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Diabetes Drugs Consumption by Type
8.3 Middle East & Africa Diabetes Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diabetes Drugs Distributors
10.3 Diabetes Drugs Customer

11 Global Diabetes Drugs Market Forecast
11.1 Global Diabetes Drugs Consumption Forecast (2021-2025)
11.2 Global Diabetes Drugs Forecast by Regions
11.2.1 Global Diabetes Drugs Forecast by Regions (2021-2025)
11.2.2 Global Diabetes Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diabetes Drugs Forecast by Type
11.8 Global Diabetes Drugs Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Diabetes Drugs Product Offered
12.1.3 Sanofi Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Hisun Pharmacy
12.2.1 Company Information
12.2.2 Diabetes Drugs Product Offered
12.2.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Hisun Pharmacy Latest Developments
12.3 Novo Nordisk
12.3.1 Company Information
12.3.2 Diabetes Drugs Product Offered
12.3.3 Novo Nordisk Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novo Nordisk Latest Developments
12.4 Astrazeneca
12.4.1 Company Information
12.4.2 Diabetes Drugs Product Offered
12.4.3 Astrazeneca Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Astrazeneca Latest Developments
12.5 Takeda
12.5.1 Company Information
12.5.2 Diabetes Drugs Product Offered
12.5.3 Takeda Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Takeda Latest Developments
12.6 MSD
12.6.1 Company Information
12.6.2 Diabetes Drugs Product Offered
12.6.3 MSD Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 MSD Latest Developments
12.7 Huadong Medicine
12.7.1 Company Information
12.7.2 Diabetes Drugs Product Offered
12.7.3 Huadong Medicine Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Huadong Medicine Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Diabetes Drugs Product Offered
12.8.3 Novartis Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Dongbao Pharmaceutical
12.9.1 Company Information
12.9.2 Diabetes Drugs Product Offered
12.9.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Dongbao Pharmaceutical Latest Developments
12.10 North China Pharmaceutical Group Corporation
12.10.1 Company Information
12.10.2 Diabetes Drugs Product Offered
12.10.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 North China Pharmaceutical Group Corporation Latest Developments
12.11 SHIJIAZHUANG YILING PHARMACEUTICAL
12.11.1 Company Information
12.11.2 Diabetes Drugs Product Offered
12.11.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 SHIJIAZHUANG YILING PHARMACEUTICAL Latest Developments
12.12 Gan & Lee
12.12.1 Company Information
12.12.2 Diabetes Drugs Product Offered
12.12.3 Gan & Lee Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Gan & Lee Latest Developments
12.13 Wanbang Biopharmaceuticals
12.13.1 Company Information
12.13.2 Diabetes Drugs Product Offered
12.13.3 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Wanbang Biopharmaceuticals Latest Developments
12.14 KELUN
12.14.1 Company Information
12.14.2 Diabetes Drugs Product Offered
12.14.3 KELUN Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 KELUN Latest Developments
12.15 Jumpcan Pharmacy
12.15.1 Company Information
12.15.2 Diabetes Drugs Product Offered
12.15.3 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Jumpcan Pharmacy Latest Developments
12.16 Tianan Pharmaceutical
12.16.1 Company Information
12.16.2 Diabetes Drugs Product Offered
12.16.3 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Tianan Pharmaceutical Latest Developments
12.17 Guangzhou Baiyun Mountain
12.17.1 Company Information
12.17.2 Diabetes Drugs Product Offered
12.17.3 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Guangzhou Baiyun Mountain Latest Developments
12.18 Ginwa
12.18.1 Company Information
12.18.2 Diabetes Drugs Product Offered
12.18.3 Ginwa Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Ginwa Latest Developments
12.19 Taloph
12.19.1 Company Information
12.19.2 Diabetes Drugs Product Offered
12.19.3 Taloph Diabetes Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Taloph Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Diabetes Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Sulphonylureas
Table 5. Major Players of Biguanides
Table 6. Major Players of Meglitinides
Table 7. Major Players of Thiazolidinediones
Table 8. Major Players of Alpha-glucosidase Inhibitors
Table 9. Major Players of DPP-4 Inhibitors
Table 10. Major Players of SGLT-2 Inhibitors
Table 11. Global Consumption Sales by Type (2015-2020)
Table 12. Global Diabetes Drugs Consumption Market Share by Type (2015-2020)
Table 13. Global Diabetes Drugs Revenue by Type (2015-2020) ($ million)
Table 14. Global Diabetes Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 15. Global Diabetes Drugs Sale Price by Type (2015-2020)
Table 16. Global Consumption Sales by Application (2015-2020)
Table 17. Global Diabetes Drugs Consumption Market Share by Application (2015-2020)
Table 18. Global Diabetes Drugs Value by Application (2015-2020)
Table 19. Global Diabetes Drugs Value Market Share by Application (2015-2020)
Table 20. Global Diabetes Drugs Sale Price by Application (2015-2020)
Table 21. Global Diabetes Drugs Sales by Company (2017-2019) (K MT)
Table 22. Global Diabetes Drugs Sales Market Share by Company (2017-2019)
Table 23. Global Diabetes Drugs Revenue by Company (2017-2019) ($ Millions)
Table 24. Global Diabetes Drugs Revenue Market Share by Company (2017-2019)
Table 25. Global Diabetes Drugs Sale Price by Company (2017-2019)
Table 26. Global Diabetes Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 27. Players Diabetes Drugs Products Offered
Table 28. Diabetes Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 29. Global Diabetes Drugs Consumption by Regions 2015-2020 (K MT)
Table 30. Global Diabetes Drugs Consumption Market Share by Regions 2015-2020
Table 31. Global Diabetes Drugs Value by Regions 2015-2020 ($ Millions)
Table 32. Global Diabetes Drugs Value Market Share by Regions 2015-2020
Table 33. Americas Diabetes Drugs Consumption by Countries (2015-2020) (K MT)
Table 34. Americas Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Table 35. Americas Diabetes Drugs Value by Countries (2015-2020) ($ Millions)
Table 36. Americas Diabetes Drugs Value Market Share by Countries (2015-2020)
Table 37. Americas Diabetes Drugs Consumption by Type (2015-2020) (K MT)
Table 38. Americas Diabetes Drugs Consumption Market Share by Type (2015-2020)
Table 39. Americas Diabetes Drugs Consumption by Application (2015-2020) (K MT)
Table 40. Americas Diabetes Drugs Consumption Market Share by Application (2015-2020)
Table 41. APAC Diabetes Drugs Consumption by Countries (2015-2020) (K MT)
Table 42. APAC Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Table 43. APAC Diabetes Drugs Value by Regions (2015-2020) ($ Millions)
Table 44. APAC Diabetes Drugs Value Market Share by Regions (2015-2020)
Table 45. APAC Diabetes Drugs Consumption by Type (2015-2020) (K MT)
Table 46. APAC Diabetes Drugs Consumption Market Share by Type (2015-2020)
Table 47. APAC Diabetes Drugs Consumption by Application (2015-2020) (K MT)
Table 48. APAC Diabetes Drugs Consumption Market Share by Application (2015-2020)
Table 49. Europe Diabetes Drugs Consumption by Countries (2015-2020) (K MT)
Table 50. Europe Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Table 51. Europe Diabetes Drugs Value by Countries (2015-2020) ($ Millions)
Table 52. Europe Diabetes Drugs Value Market Share by Countries (2015-2020)
Table 53. Europe Diabetes Drugs Consumption by Type (2015-2020) (K MT)
Table 54. Europe Diabetes Drugs Consumption Market Share by Type (2015-2020)
Table 55. Europe Diabetes Drugs Consumption by Application (2015-2020) (K MT)
Table 56. Europe Diabetes Drugs Consumption Market Share by Application (2015-2020)
Table 57. Middle East & Africa Diabetes Drugs Consumption by Countries (2015-2020) (K MT)
Table 58. Middle East & Africa Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Diabetes Drugs Value by Countries (2015-2020) ($ Millions)
Table 60. Middle East & Africa Diabetes Drugs Value Market Share by Countries (2015-2020)
Table 61. Middle East & Africa Diabetes Drugs Consumption by Type (2015-2020) (K MT)
Table 62. Middle East & Africa Diabetes Drugs Consumption Market Share by Type (2015-2020)
Table 63. Middle East & Africa Diabetes Drugs Consumption by Application (2015-2020) (K MT)
Table 64. Middle East & Africa Diabetes Drugs Consumption Market Share by Application (2015-2020)
Table 65. Diabetes Drugs Distributors List
Table 66. Diabetes Drugs Customer List
Table 67. Global Diabetes Drugs Consumption Forecast by Countries (2021-2025) (K MT)
Table 68. Global Diabetes Drugs Consumption Market Forecast by Regions
Table 69. Global Diabetes Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 70. Global Diabetes Drugs Value Market Share Forecast by Regions
Table 71. Global Diabetes Drugs Consumption Forecast by Type (2021-2025) (K MT)
Table 72. Global Diabetes Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 73. Global Diabetes Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 74. Global Diabetes Drugs Value Market Share Forecast by Type (2021-2025)
Table 75. Global Diabetes Drugs Consumption Forecast by Application (2021-2025) (K MT)
Table 76. Global Diabetes Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 77. Global Diabetes Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 78. Global Diabetes Drugs Value Market Share Forecast by Application (2021-2025)
Table 79. Sanofi Product Offered
Table 80. Sanofi Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Sanofi Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Hisun Pharmacy Product Offered
Table 85. Hisun Pharmacy Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 86. Hisun Pharmacy Main Business
Table 87. Hisun Pharmacy Latest Developments
Table 88. Hisun Pharmacy Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Novo Nordisk Product Offered
Table 90. Novo Nordisk Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 91. Novo Nordisk Main Business
Table 92. Novo Nordisk Latest Developments
Table 93. Novo Nordisk Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Astrazeneca Product Offered
Table 95. Astrazeneca Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 96. Astrazeneca Main Business
Table 97. Astrazeneca Latest Developments
Table 98. Astrazeneca Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Takeda Product Offered
Table 100. Takeda Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 101. Takeda Main Business
Table 102. Takeda Latest Developments
Table 103. Takeda Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. MSD Product Offered
Table 105. MSD Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 106. MSD Main Business
Table 107. MSD Latest Developments
Table 108. MSD Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Huadong Medicine Product Offered
Table 110. Huadong Medicine Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Huadong Medicine Main Business
Table 112. Huadong Medicine Latest Developments
Table 113. Huadong Medicine Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 114. Novartis Product Offered
Table 115. Novartis Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Novartis Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Dongbao Pharmaceutical Product Offered
Table 120. Dongbao Pharmaceutical Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 121. Dongbao Pharmaceutical Main Business
Table 122. Dongbao Pharmaceutical Latest Developments
Table 123. Dongbao Pharmaceutical Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. North China Pharmaceutical Group Corporation Product Offered
Table 125. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 126. North China Pharmaceutical Group Corporation Main Business
Table 127. North China Pharmaceutical Group Corporation Latest Developments
Table 128. North China Pharmaceutical Group Corporation Basic Information, Company Total Revenue (in $ million), Diabetes Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. SHIJIAZHUANG YILING PHARMACEUTICAL Product Offered
Table 130. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 131. SHIJIAZHUANG YILING PHARMACEUTICAL Main Business
Table 132. SHIJIAZHUANG YILING PHARMACEUTICAL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. SHIJIAZHUANG YILING PHARMACEUTICAL Latest Developments
Table 134. Gan & Lee Product Offered
Table 135. Gan & Lee Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 136. Gan & Lee Main Business
Table 137. Gan & Lee Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 138. Gan & Lee Latest Developments
Table 139. Wanbang Biopharmaceuticals Product Offered
Table 140. Wanbang Biopharmaceuticals Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 141. Wanbang Biopharmaceuticals Main Business
Table 142. Wanbang Biopharmaceuticals Latest Developments
Table 143. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. KELUN Product Offered
Table 145. KELUN Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 146. KELUN Main Business
Table 147. KELUN Latest Developments
Table 148. KELUN Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Jumpcan Pharmacy Product Offered
Table 150. Jumpcan Pharmacy Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 151. Jumpcan Pharmacy Main Business
Table 152. Jumpcan Pharmacy Latest Developments
Table 153. Jumpcan Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Tianan Pharmaceutical Product Offered
Table 155. Tianan Pharmaceutical Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 156. Tianan Pharmaceutical Main Business
Table 157. Tianan Pharmaceutical Latest Developments
Table 158. Tianan Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Guangzhou Baiyun Mountain Product Offered
Table 160. Guangzhou Baiyun Mountain Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 161. Guangzhou Baiyun Mountain Main Business
Table 162. Guangzhou Baiyun Mountain Latest Developments
Table 163. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Ginwa Product Offered
Table 165. Ginwa Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 166. Ginwa Main Business
Table 167. Ginwa Latest Developments
Table 168. Ginwa Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Taloph Product Offered
Table 170. Taloph Diabetes Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 171. Taloph Main Business
Table 172. Taloph Latest Developments
Table 173. Taloph Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Diabetes Drugs
Figure 2. Diabetes Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Diabetes Drugs Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Diabetes Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Sulphonylureas
Figure 7. Product Picture of Biguanides
Figure 8. Product Picture of Meglitinides
Figure 9. Product Picture of Thiazolidinediones
Figure 10. Product Picture of Alpha-glucosidase Inhibitors
Figure 11. Product Picture of DPP-4 Inhibitors
Figure 12. Product Picture of SGLT-2 Inhibitors
Figure 13. Global Diabetes Drugs Consumption Market Share by Type (2015-2020)
Figure 14. Global Diabetes Drugs Value Market Share by Type (2015-2020)
Figure 15. Diabetes Drugs Consumed in Diagnostic/Clinics
Figure 16. Global Diabetes Drugs Market: Diagnostic/Clinics (2015-2020) (K MT)
Figure 17. Global Diabetes Drugs Market: Diagnostic/Clinics (2015-2020) ($ Millions)
Figure 18. Diabetes Drugs Consumed in ICUs
Figure 19. Global Diabetes Drugs Market: ICUs (2015-2020) (K MT)
Figure 20. Global Diabetes Drugs Market: ICUs (2015-2020) ($ Millions)
Figure 21. Diabetes Drugs Consumed in Home Healthcare
Figure 22. Global Diabetes Drugs Market: Home Healthcare (2015-2020) (K MT)
Figure 23. Global Diabetes Drugs Market: Home Healthcare (2015-2020) ($ Millions)
Figure 24. Global Diabetes Drugs Consumption Market Share by Application (2015-2020)
Figure 25. Global Diabetes Drugs Value Market Share by Application (2015-2020)
Figure 26. Global Diabetes Drugs Sales Market Share by Company in 2017
Figure 27. Global Diabetes Drugs Sales Market Share by Company in 2019
Figure 28. Global Diabetes Drugs Revenue Market Share by Company in 2017
Figure 29. Global Diabetes Drugs Revenue Market Share by Company in 2019
Figure 30. Global Diabetes Drugs Sale Price by Company in 2019
Figure 31. Global Diabetes Drugs Consumption Market Share by Regions 2015-2020
Figure 32. Global Diabetes Drugs Value Market Share by Regions 2015-2020
Figure 33. Americas Diabetes Drugs Consumption 2015-2020 (K MT)
Figure 34. Americas Diabetes Drugs Value 2015-2020 ($ Millions)
Figure 35. APAC Diabetes Drugs Consumption 2015-2020 (K MT)
Figure 36. APAC Diabetes Drugs Value 2015-2020 ($ Millions)
Figure 37. Europe Diabetes Drugs Consumption 2015-2020 (K MT)
Figure 38. Europe Diabetes Drugs Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Diabetes Drugs Consumption 2015-2020 (K MT)
Figure 40. Middle East & Africa Diabetes Drugs Value 2015-2020 ($ Millions)
Figure 41. Americas Diabetes Drugs Consumption Market Share by Countries in 2019
Figure 42. Americas Diabetes Drugs Value Market Share by Countries in 2019
Figure 43. Americas Diabetes Drugs Consumption Market Share by Type in 2019
Figure 44. Americas Diabetes Drugs Consumption Market Share by Application in 2019
Figure 45. United States Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 46. United States Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 48. Canada Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 50. Mexico Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Diabetes Drugs Consumption Market Share by Countries in 2019
Figure 52. APAC Diabetes Drugs Value Market Share by Regions in 2019
Figure 53. APAC Diabetes Drugs Consumption Market Share by Type in 2019
Figure 54. APAC Diabetes Drugs Consumption Market Share by Application in 2019
Figure 55. China Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 56. China Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 58. Japan Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 60. Korea Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 62. Southeast Asia Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 63. India Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 64. India Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 66. Australia Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Diabetes Drugs Consumption Market Share by Countries in 2019
Figure 68. Europe Diabetes Drugs Value Market Share by Countries in 2019
Figure 69. Europe Diabetes Drugs Consumption Market Share by Type in 2019
Figure 70. Europe Diabetes Drugs Consumption Market Share by Application in 2019
Figure 71. Germany Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 72. Germany Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 73. France Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 74. France Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 75. UK Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 76. UK Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 78. Italy Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 80. Russia Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Diabetes Drugs Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Diabetes Drugs Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Diabetes Drugs Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Diabetes Drugs Consumption Market Share by Application in 2019
Figure 85. Egypt Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 86. Egypt Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 88. South Africa Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Diabetes Drugs Consumption Growth 2015-2020 (K MT)
Figure 90. Israel Diabetes Drugs Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Diabetes Drugs Consumption Growth 2015-2020 (K MT)
  • Global Liraglutide Market Growth 2020-2025
    Published: 17-Sep-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Liraglutide market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Liraglutide business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide market by product type, application, ......
  • Global Insulin API Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 17-Sep-2020        Price: US 3400 Onwards        Pages: 122
    The Insulin API market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Insulin API market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Insulin API market. The report focuses on well-known providers in the global Insulin API industry, market segments, competition, and the macro environment. ......
  • Global Diabetes Drugs Market Growth 2020-2025
    Published: 15-Sep-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Diabetes Drugs market will register a 5.6%% CAGR in terms of revenue, the global market size will reach $ 77400 million by 2025, from $ 62240 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diabetes Drugs business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Drugs market by product typ......
  • Global Insulin Glargine Market Growth 2020-2025
    Published: 15-Sep-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Insulin Glargine market will register a 4.1%% CAGR in terms of revenue, the global market size will reach $ 7106.7 million by 2025, from $ 6040 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin Glargine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Glargine market by produ......
  • 2020-2029 Report on Global Liraglutide Market by Player, Region, Type, Application and Sales Channel
    Published: 14-Sep-2020        Price: US 2500 Onwards        Pages: 102
    The global Liraglutide market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in ......
  • Global and China Incretin-Based Drugs Market Insights, Forecast to 2026
    Published: 11-Sep-2020        Price: US 3900 Onwards        Pages: 129
    Incretin-Based Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Incretin-Based Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Incretin-Based Drugs market is ......
  • Global and China Lixisenatide Market Insights, Forecast to 2026
    Published: 11-Sep-2020        Price: US 3900 Onwards        Pages: 134
    Lixisenatide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lixisenatide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Lixisenatide market is segmented into - ......
  • Global Metformin Hydrochloride Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 10-Sep-2020        Price: US 3400 Onwards        Pages: 114
    The Metformin Hydrochloride market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Metformin Hydrochloride market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Metformin Hydrochloride market. The report focuses on well-known providers in the global Metformin Hydrochloride industry, market segments, ......
  • Global and China Insulin (API & Injection) Market Insights, Forecast to 2026
    Published: 08-Sep-2020        Price: US 3900 Onwards        Pages: 127
    Insulin (API & Injection) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Insulin (API & Injection) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Insulin (API & Inject......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs